Table 2.

Catheter outcomes in the study population

Heparin CoatedNoncoated
Number of patients8986
Catheter malfunction [N (%)]17 (19%)13 (15%)
Catheter-related bacteremia [N (%)]30 (34%)a52 (60%)
Elective removal [N (%)]31 (35%)17 (20%)
Remained patent [N (%)]11 (12%)4 (5%)
tPA instillations per 1000 catheter-days1.81.8
  • a P < 0.001 versus noncoated catheters.

  • tPA, tissue plasminogen activator.